Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Chyloperitoneum in a peritoneal dialysis patient.

Levy RI, Wenk RE.

Am J Kidney Dis. 2001 Sep;38(3):E12.

PMID:
11532714
2.

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.

Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, Levy RI, Hulley SB.

JAMA. 2000 Apr 12;283(14):1845-52.

PMID:
10770146
3.

Primordial prevention of cardiovascular disease risk factors: panel summary.

Stamler J, Fortmann SP, Levy RI, Prineas RJ, Tell G.

Prev Med. 1999 Dec;29(6 Pt 2):S130-5. No abstract available.

PMID:
10641831
4.

Dedicated research institute keeps Wyeth-Ayerst focused on women's health.

Levy RI.

J Womens Health. 1997 Feb;6(1):45-7. No abstract available.

PMID:
9065373
5.

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.

Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, Abolafia JM, Lippel K, Levy RI.

JAMA. 1994 Apr 6;271(13):999-1003.

PMID:
8139085
6.

A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin.

Levy RI, Troendle AJ, Fattu JM.

Circulation. 1993 Apr;87(4 Suppl):III45-53. Review.

PMID:
8462180
7.

AHA Conference Report on Cholesterol. Intervention studies.

Levy RI, Blankenhorn D, Davis CE, Gordon DJ, Furberg C, Huttunen J, Levine RJ, Passamani E, Yusuf S.

Circulation. 1989 Sep;80(3):739-43. Review. No abstract available.

PMID:
2670325
8.

Current therapy for hypercholesterolemia.

Blum CB, Levy RI.

JAMA. 1989 Jun 23-30;261(24):3582-7. Review. No abstract available.

PMID:
2657125
9.

Progression of coronary atherosclerosis in patients with probable familial hypercholesterolemia. Quantitative arteriographic assessment of patients in NHLBI type II study.

Brown BG, Lin JT, Kelsey S, Passamani ER, Levy RI, Dodge HT, Detre KM.

Arteriosclerosis. 1989 Jan-Feb;9(1 Suppl):I81-90.

PMID:
2912435
10.

Currently available lipid-lowering agents.

Levy RI.

Hosp Pract (Off Ed). 1988 Jun;23 Suppl 1:14-21. Review. No abstract available.

PMID:
3134381
11.

Report on the Lipid Research Clinic trials.

Levy RI.

Eur Heart J. 1987 Aug;8 Suppl E:45-53.

PMID:
3315677
12.

Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men.

Krauss RM, Lindgren FT, Williams PT, Kelsey SF, Brensike J, Vranizan K, Detre KM, Levy RI.

Lancet. 1987 Jul 11;2(8550):62-6.

PMID:
2885572
14.

The risks of moderate drinking.

Blume S, Levy RI, Kannel WB, Takamine J.

JAMA. 1986 Dec 19;256(23):3213-4. No abstract available.

PMID:
3783857
15.

Rational drug therapy of the hyperlipoproteinemias, Part II.

Blum CB, Levy RI.

Ration Drug Ther. 1986 Oct;20(10):1-4. No abstract available.

PMID:
3472266
16.

Rational drug therapy of the hyperlipoproteinemias, Part I.

Blum CB, Levy RI.

Ration Drug Ther. 1986 Sep;20(9):1-7. No abstract available.

PMID:
3575746
17.

IAIMS at Columbia: a strategic plan and model project.

Hendrickson GL, Anderson RK, Levy RI.

Bull Med Libr Assoc. 1986 Jul;74(3):243-8.

18.

Changing perspectives in the prevention of coronary artery disease.

Levy RI.

Am J Cardiol. 1986 May 30;57(14):17G-26G. Review.

PMID:
3087152
19.

Planning and implementation of large clinical trials.

Friedewald WT, Levy RI.

Isr J Med Sci. 1986 Mar-Apr;22(3-4):191-6.

PMID:
3528041
20.

Cholesterol and coronary artery disease. What do clinicians do now?

Levy RI.

Am J Med. 1986 Feb 14;80(2A):18-22.

PMID:
3946457
21.

Some clinical implications of the results of the Lipid Research Clinics Program Prevalence Study.

LaRosa JC, Levy RI, Hazzard WR.

Circulation. 1986 Jan;73(1 Pt 2):I126-33. No abstract available.

PMID:
3940680
22.

Secondary prevention and lipid lowering: results and implications.

Detre KM, Levy RI, Kelsey SF, Epstein SE, Brensike JF, Passamani ER, Richardson JM, Loh IK, Stone NJ, Aldrich RF, et al.

Am Heart J. 1985 Nov;110(5):1123-7.

PMID:
3904378
23.
24.

Cholesterol and cardiovascular disease: no longer whether, but rather when, in whom, and how?

Levy RI.

Circulation. 1985 Oct;72(4):686-91. No abstract available.

PMID:
3896559
25.

Pathogenesis and management of lipoprotein disorders.

Schaefer EJ, Levy RI.

N Engl J Med. 1985 May 16;312(20):1300-10. Review. No abstract available.

PMID:
3887163
26.

[Verification of the lipid hypothesis by drug intervention].

Levy RI.

Ter Arkh. 1985;57(11):33-5. Russian. No abstract available.

PMID:
3909475
27.

Causes of the decrease in cardiovascular mortality.

Levy RI.

Am J Cardiol. 1984 Aug 27;54(5):7C-13C.

PMID:
6475765
28.

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.

Levy RI, Brensike JF, Epstein SE, Kelsey SF, Passamani ER, Richardson JM, Loh IK, Stone NJ, Aldrich RF, Battaglini JW, et al.

Circulation. 1984 Feb;69(2):325-37.

PMID:
6360415
29.

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.

Brensike JF, Levy RI, Kelsey SF, Passamani ER, Richardson JM, Loh IK, Stone NJ, Aldrich RF, Battaglini JW, Moriarty DJ, et al.

Circulation. 1984 Feb;69(2):313-24.

PMID:
6360414
30.

The dilemma of 'mild' hypertension. Another viewpoint of treatment.

Gifford RW Jr, Borhani N, Krishan I, Moser M, Levy RI, Schoenberger JA.

JAMA. 1983 Dec 16;250(23):3171-3. No abstract available.

PMID:
6645006
31.

The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females.

Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer HB Jr, Levy RI.

J Clin Endocrinol Metab. 1983 Aug;57(2):262-7.

PMID:
6408108
32.

Current status of the cholesterol controversy.

Levy RI.

Am J Med. 1983 May 23;74(5A):1-4.

PMID:
6342382
33.

The attack on mead.

Levy RI.

Science. 1983 May 20;220(4599):829-32. No abstract available.

PMID:
17834178
34.

Cholesterol and disease--what are the facts?

Levy RI.

JAMA. 1982 Dec 3;248(21):2888-90. No abstract available.

PMID:
7143656
35.

Reliability of assessing change with sequential coronary angiography.

Detre KM, Kelsey SF, Passamani ER, Fisher MR, Brensike JF, Battaglini JW, Richardson JM, Loh IK, Stone NJ, Aldrich RF, Levy RI, Epstein SE.

Am Heart J. 1982 Oct;104(4 Pt 1):816-23.

PMID:
7124596
36.

Consideration of cholesterol and noncardiovascular mortality.

Levy RI.

Am Heart J. 1982 Aug;104(2 Pt 1):324-8. Review. No abstract available.

PMID:
7048876
37.

Cardiovascular research: decades of progress, a decade of promise.

Levy RI, Moskowitz J.

Science. 1982 Jul 9;217(4555):121-9. Review.

PMID:
7046047
38.

National Heart, Lung, and Blood Institute type II Coronary Intervention Study: design, methods, and baseline characteristics.

Brensike JF, Kelsey SF, Passamani ER, Fisher MR, Richardson JM, Loh IK, Stone NJ, Aldrich RF, Battaglini JW, Moriarty DJ, Myrianthopoulos MB, Detre KM, Epstein SE, Levy RI.

Control Clin Trials. 1982 Jun;3(2):91-111.

PMID:
6749427
39.

Clinical trials: are the benefits worth the costs?

Levy RI.

Clin Res. 1982 Apr;30(2):116-22. No abstract available.

PMID:
10309771
40.

Initiating large-scale clinical trials.

Levy RI, Sondik EJ.

Control Clin Trials. 1982 Mar;3(1):29-46.

PMID:
6121683
41.
42.

Large-scale clinical trials: are they worth the cost?

Levy RI, Sondik EJ.

Ann N Y Acad Sci. 1982;382:411-22. No abstract available.

PMID:
6805385
43.

Declining mortality in coronary heart disease.

Levy RI.

Arteriosclerosis. 1981 Sep-Oct;1(5):312-25. Review.

PMID:
7052033
44.
45.

Percutaneous transluminal coronary angioplasty-a status report.

Levy RI, Mock MB, Willman VL, Passamani ER, Frommer PL.

N Engl J Med. 1981 Aug 13;305(7):399-400. No abstract available.

PMID:
7019708
46.
47.

Hypertension education: a federal perspective.

Levy RI, Admire JB.

Fam Community Health. 1981 May;4(1):97-109. No abstract available.

PMID:
10250958
48.

The physician and prevention.

Levy RI.

Am J Cardiol. 1981 Mar;47(3):718-9. No abstract available.

PMID:
7468507
49.

New tools for treating heart disease.

Levy RI.

Am Pharm. 1981 Mar;NS21(3):16-23. No abstract available.

PMID:
7223617
50.

The decline in cardiovascular disease mortality.

Levy RI.

Annu Rev Public Health. 1981;2:49-70. No abstract available.

PMID:
7348559

Supplemental Content

Support Center